C12N 2770/36022
New viral proteins or individual genes, new structural or functional aspects of
Official title: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N2770/36022 (New viral proteins or individual genes, new structural or functional aspects of) appears on 14 US grants and 5 published applications in this corpus.
Search patents in C12N- Granted patents
- 14
- Published applications
- 5
- Assignees
- 9
- Inventors
- 38
- Latest grant
- 23 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 5 | 0 |
| 1999 | 4 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 1 |
| 2003 | 2 | 0 |
| 2004 | 1 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 2 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for therapeutic delivery23 Dec 2025US 12,502,437 B2GenVivo, Inc.
- Immunodominant human T-cell epitopes of hepatitis C virus10 Feb 2004US 6,689,368 B1Innogenetics N. V.
- Immunodominant human T-cell epitopes of hepatitis C virus2 Sep 2003US 6,613,333 B1Innogenetics N. V.
- Immunodominant human T-cell epitopes of hepatitis C virus29 Apr 2003US 6,555,114 B1Innogenetics N. V.
- Hepatitis GB virus recombinant proteins and uses thereof5 Dec 2000US 6,156,495 AAbbott Laboratories
- Compositions and methods for therapeutic delivery5 Mar 2026US 2026/0061072 A1GenVivo, Inc.
- Compositions and methods for therapeutic delivery29 May 2025US 2025/0170271 A1GenVivo, Inc.
- Recombinant baculoviruses, vaccine compositions that comprise it, and methods for inducing an immune response2 Jan 2025US 2025/0000961 A1Instituto Nacional De Tecnologia Agropecuaria
- Immunodominant human T-cell epitopes of hepatitis C virus11 Mar 2004US 2004/0047877 A1Innogenetics N.V.
- Replication competent herpes virus strains19 Dec 2002US 2002/0192802 A1
Most cited
By later US patents
- Immunodominant human T-cell epitopes of hepatitis C virus38US 6,555,114 B1Innogenetics N. V. · 2003
- Hepatitis G virus and molecular cloning thereof19US 5,766,840 AGenelabs Technologies, Inc. · 1998
- Immunodominant human T-cell epitopes of hepatitis C virus17US 6,613,333 B1Innogenetics N. V. · 2003
- Hepatitis GB Virus synthetic peptides and uses thereof16US 5,843,450 AAbbott Laboratories · 1998
- Hepatitis G virus and molecular cloning thereof9US 5,824,507 AGenelabs Technologies, Inc. · 1998